Community resources and publications
TAG hepatitis C pipeline report
FDA approval of two hepatitis C-specific protease inhibitors, the first of the coming wave of oral antiviral drugs, is anticipated later this year. Dozens of drugs are in development to fight hepatitis C virus (HCV).
The Treatment Action Group 2011 Hepatitis C Treatment Pipeline Report is a comprehensive overview of drugs in clinical trials. The Pipeline covers a range of issues, including diagnostics, drug resistance, access to, and delivery of treatment, and population-specific focus on the new HCV drugs, as well as research recommendations.